AbbVievsNRC Health

ABBV and NRC stock compared: price, dividend, valuation and results, from SEC filings.

NRC

NRC Health

$26.33

Value $559M

-0.87%
NRC's page

AbbVie (ABBV) has a market value of $521B and NRC Health (NRC) $559M. Over the last year, with dividends, ABBV moved +30.6% and NRC +78.8%. The P/E is 50.6 for ABBV and 91.1 for NRC. Dividend yield: ABBV 2.35%, NRC 2.43%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$521B

    NRC$559M

    ABBV is 932 times NRC

  • Revenue, 12 months

    ABBV$66.0B

    NRC$144M

    ABBV is 459 times NRC

  • Net income, 12 months

    ABBV$10.3B

    NRC$6.1M

    ABBV is 1,687 times NRC

  • Operating margin

    ABBV32.2%

    NRC11.1%

    21.1 points apart

  • ROIC

    ABBV25.7%

    NRC10.4%

    15.3 points apart

  • P/E

    ABBV50.6

    NRC91.1

    NRC is 1.8 times ABBV

  • Dividend yield

    ABBV2.4%

    NRC2.4%

    About the same

  • 5-year return

    ABBV+201.4%

    NRC-34.9%

    236.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.4%

NRC-34.9%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsNRCWith dividends
1 year since November 14, 2025+30.6%Price +26.8%+78.8%Price +72.9%
3 years since November 16, 2023+135.5%+33.0% a yearPrice +113.0%-30.9%-11.6% a yearPrice -36.4%
5 years since November 15, 2021+201.4%+24.7% a yearPrice +152.1%-34.9%-8.2% a yearPrice -43.3%
10 years since November 16, 2016+619.6%+21.8% a yearPrice +378.6%+103.2%+7.3% a yearPrice +64.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieNRCNRC Health

Valuation

ABBVNRC
Valuation
Price$294.55$26.33
Market value$521B$559M
Enterprise value (EV)$591B$658M
P/E50.691.1
P/E, 5-year median57.028.4
P/B––
EV/EBIT27.841.4
Free cash flow yield3.6%3.3%

Results and growth

ABBVNRC
Results and growth
Revenue, 12 months$66.0B$144M
Net income, 12 months$10.3B$6.1M
Free cash flow, 12 months$18.9B$18M
Earnings per share, 12 months$5.81$0.27
Revenue growth, year on year8.6%-4.0%
Revenue growth a year, past+5.9%over 5 years+0.6%over 5 years
EPS growth a year, past-2.8%over 5 years+103.0%over 5 years

Margins and returns on capital

ABBVNRC
Margins and returns on capital
Gross margin73.7%–
Operating margin32.2%11.1%
Net margin15.7%4.3%
ROIC25.7%10.4%
ROE–78.2%

Balance sheet

ABBVNRC
Balance sheet
Cash$10.8B$3.6M
Total debt$80.9B$103M
Net debt / EBITDA3.24.2
Interest cover7.1×2.9×

Dividends and buybacks

ABBVNRC
Dividends and buybacks
Dividend yield2.4%2.4%
Dividend per share, 12 months$6.92$0.64
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%3.6%
Shareholder yield2.5%6.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or NRC

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or NRC Health?

By market value, AbbVie ($521B) is about 932.1 times NRC Health ($559M), at today's prices.

How did ABBV and NRC stock do over the last 10 years?

Since November 16, 2016, ABBV's price moved +378.6% and NRC's +64.0%. With dividends: ABBV +619.6% (+21.8% a year), NRC +103.2% (+7.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or NRC?

The dividend yield at today's price is 2.35% for AbbVie and 2.43% for NRC Health. Over the last twelve months they paid $6.92 and $0.64 per share.

What is the P/E of ABBV and NRC?

At today's price, the P/E is 50.6 for ABBV and 91.1 for NRC. The median of the last five years was 57.0 and 28.4, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or NRC Health?

Over the last twelve months, the net margin was 15.7% for AbbVie and 4.3% for NRC Health, and the operating margin 32.2% and 11.1%. Revenue was $66.0B and $144M.

Which is the better investment, AbbVie or NRC Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.